Market OverviewThe global Cancer Immunotherapy Market is valued at USD 121.4 Billion in 2024 and is projected to reach a ...

A new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to ...

Shares of Regeneron Pharmaceuticals, Inc. REGN have lost 22.6% year to date against the industry’s growth of 0.6%. The stock ...

Abviax's Obefazimod shows strong potential in ulcerative colitis treatment. Upcoming phase 3 trial data in Q3 2025 is a key ...

President Donald Trump was recently diagnosed with chronic venous insufficiency, a medical condition that’s the result of damaged leg veins struggling to pump blood to the heart.